Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions

Journal of Neuroimmunology

Volumn 136, Issue 1-2, 2003, Pages 140-148

  O'Connor, Kevin C ^a   Chitnis, Tanuja ^a   Griffin, Diane E ^b   Piyasirisilp, Sucheep ^b   Bar Or, Amit ^c   Khoury, Samia ^a   Wucherpfennig, Kai W ^d   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Antibodies; Autoimmunity; Diabetes; EAE MS; Human; Myelin basic protein

Indexed keywords

AUTOANTIBODY; MYELIN BASIC PROTEIN; RABIES VACCINE;

ACCURACY; ANALYTIC METHOD; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DEMYELINATING DISEASE; HUMAN; IMMUNIZATION; IMMUNOASSAY; INTERMETHOD COMPARISON; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0037333270     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00002-X     Document Type: Article

References (45)

1. Banki K., Colombo E., Sia F., Halladay D., Mattson D.H., Tatum A.H., Massa P.T., Phillips P.E., Perl A. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J. Exp. Med. 180:1994;1649-1663.
2. Bao F., Yu L., Babu S., Wang T., Hoffenberg E.J., Rewers M., Eisenbarth G.S. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J. Autoimmun. 13:1999;143-148.
3. Bonamico M., Tiberti C., Picarelli A., Mariani P., Rossi D., Cipolletta E., Greco M., Tola M.D., Sabbatella L., Carabba B., Magliocca F.M., Strisciuglio P., Di Mario U. Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am. J. Gastroenterol. 96:2001;1536-1540.
4. Brokstad K.A., Page M., Nyland H., Haaheim L.R. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients. Acta Neurol. Scand. 89:1994;407-411.
5. Bronstein J.M., Lallone R.L., Seitz R.S., Ellison G.W., Myers L.W. A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic. Neurology. 53:1999;154-161.
6. Butler J.E. The behavior of antigens and antibodies immobilized on a solid phase. Van Regenmortel M.H.V. Structure of Antigens. vol. 1:1992;209-260 CRC Press, Boca Raton.
7. Butler J.E., Ni L., Brown W.R., Joshi K.S., Chang J., Rosenberg B., Voss E.W. Jr. The immunochemistry of sandwich ELISAs: VI. Greater than 90% of monoclonal and 75% of polyclonal anti-fluorescyl capture antibodies (CAbs) are denatured by passive adsorption. Mol. Immunol. 30:1993;1165-1175.
8. Catz I., Warren K.G. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis. Can. J. Neurol. Sci. 13:1986;21-24.
9. Chou C.H., Tourtellotte W.W., Kibler R.F. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology. 33:1983;24-28.
10. Colombo E., Banki K., Tatum A.H., Daucher J., Ferrante P., Murray R.S., Phillips P.E., Perl A. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J. Clin. Invest. 99:1997;1238-1250.
11. Cortese I., Tafi R., Grimaldi L.M., Martino G., Nicosia A., Cortese R. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11063-11067.
12. Cross A.H., Trotter J.L., Lyons J. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112:2001;1-14.
13. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
14. Greenbaum C.J., Palmer J.P., Kuglin B., Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J. Clin. Endocrinol. Metab. 74:1992;1040-1044.
15. Haase C.G., Guggenmos J., Brehm U., Andersson M., Olsson T., Reindl M., Schneidewind J.M., Zettl U.K., Heidenreich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:2001;220-225.
16. Kamholz J., de Ferra F., Puckett C., Lazzarini R. Identification of three forms of human myelin basic protein by cDNA cloning. Proc. Natl. Acad. Sci. U. S. A. 83:1986;4962-4966.
17. Kappos L., Comi G., Panitch H., Oger J., Antel J., Conlon P., Steinman L. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat. Med. 6:2000;1176-1182.
18. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:1987;947-950.
19. Leslie D., Lipsky P., Notkins A.L. Autoantibodies as predictors of disease. J. Clin. Invest. 108:2001;1417-1422.
20. Lowenthal A., Van Sande M., Karcher D. The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF G-globulins. J. Neurochem. 235:1960;229-233.
21. McNeil H.P., Chesterman C.N., Krilis S.A. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49:1991;193-280.
22. Moller J.R., Johnson D., Brady R.O., Tourtellotte W.W., Quarles R.H. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 22:1989;55-61.
23. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343:2000;938-952.
24. O'Connor K.C., Bar-Or A., Hafler D.A. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol. 21:2001;81-92.
25. Olsson T., Baig S., Hojeberg B., Link H. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 27:1990;132-136.
26. Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., Hoier-Madsen M., Boel E., Michelsen B.K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 43:1994;459-467.
27. Piyasirisilp S., Hemachudha T., Griffin D.E. B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine. J. Neuroimmunol. 98:1999;96-104.
28. Qin Y., Duquette P., Zhang Y., Talbot P., Poole R., Antel J. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 102:1998;1045-1050.
29. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain. 122:1999;2047-2056.
30. Seissler J., Wagner S., Schott M., Lettmann M., Feldkamp J., Scherbaum W.A., Morgenthaler N.G. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 85:2000;4630-4634.
31. Sodoyez-Goffaux F., Koch M., Dozio N., Brandenburg D., Sodoyez J.C. Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies. Diabetologia. 31:1988;694-702.
32. Stollar B.D. The origin and pathogenic role of anti-DNA autoantibodies. Curr. Opin. Immunol. 2:1989;607-612.
33. Terryberry J.W., Thor G., Peter J.B. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol. Aging. 19:1998;205-216.
34. Union A., Meheus L., Humbel R.L., Conrad K., Steiner G., Moereels H., Pottel H., Serre G., De Keyser F. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum. 46:2002;1185-1195.
35. Warren K.G., Catz I. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis. Ann. Neurol. 20:1986;20-25.
36. Warren K.G., Catz I. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 96:1990;19-27.
37. Warren K.G., Catz I. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis. J. Neuroimmunol. 43:1993;87-96.
38. Warren K.G., Catz I. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J. Neurol. Sci. 121:1994;66-73.
39. Warren K.G., Catz I. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis. Eur. Neurol. 42:1999;95-104.
40. Whitaker J.N., Beneveniste E.N. Cerebrospinal fluid. Cook S.D. Handbook of Multiple Sclerosis. 1996;295-316 Marcel Dekker, New York.
41. Wilkin T.J., Schoenfeld S.L., Diaz J.L., Kruse V., Bonifacio E., Palmer J.P. Systematic variation and differences in insulin-autoantibody measurements. Diabetes. 38:1989;172-181.
42. Williamson R.A., Burgoon M.P., Owens G.P., Ghausi O., Leclerc E., Firme L., Carlson S., Corboy J., Parren P.W., Sanna P.P., Gilden D.H., Burton D.R. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1793-1798.
43. Wucherpfennig K.W., Catz I., Hausmann S., Strominger J.L., Steinman L., Warren K.G. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100:1997;1114-1122.
44. Xiao B.G., Linington C., Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:1991;91-96.
45. Yamamoto A.M., Johanet C., Duclos-Vallee J.C., Bustarret F.A., Alvarez F., Homberg J.C., Bach J.F. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay. Clin. Exp. Immunol. 108:1997;396-400.